About Epirubicin Hydrochloride
            
            Class: | Anthracycline antibiotic  
Use: | Treatment of various cancers, including breast cancer, bladder cancer, and lung cancer; often used in combination chemotherapy regimens.  
Adult dose: | Typically, 60-120 mg/m² administered intravenously every 3-4 weeks, depending on the specific cancer type and treatment protocol.  
Pediatric dose: | Dosing is individualized based on body surface area; generally, 75-100 mg/m² every 3-4 weeks for certain pediatric cancers.  
Side effects: | Common side 
         
        
            
                
                
                    
                        Drug Class
                    
                    Anthracycline antibiotic
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of various cancers, including breast cancer, bladder cancer, and lung cancer; often used in combination chemotherapy regimens.
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20-25°C or 68-77°F); protect from light and moisture; reconstituted solutions should be used immediately or stored at 2-8°C for no more than 24 hours.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Pharmacia & Upjohn S.p.A., ITALY
                    
                    
                    Package Size
                    5ml Vial + 1 Solvent Ampoule (5ml)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 83.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Typically, 60-120 mg/m² administered intravenously every 3-4 weeks, depending on the specific cancer type and treatment protocol.
                    
                    
                        Pediatric Dose
                    
                    
                        Dosing is individualized based on body surface area; generally, 75-100 mg/m² every 3-4 weeks for certain pediatric cancers.
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include nausea, vomiting, hair loss, fatigue, myelosuppression (decreased blood cell counts), and mucositis.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to epirubicin or any component of the formulation; severe myocardial insufficiency; recent myocardial infarction; and severe liver impairment.
         
        
        
            
                Important Warnings
            
            Risk of cardiotoxicity, especially with cumulative doses; monitor cardiac function; potential for secondary malignancies; use with caution in patients with pre-existing heart conditions or those receiving other cardiotoxic agents.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.